MARKET

GMAB

GMAB

Genmab
NASDAQ
51.74
-2.13
-3.95%
After Hours: 52.00 +0.26 +0.50% 19:41 11/12 EST
OPEN
52.20
PREV CLOSE
53.87
HIGH
53.03
LOW
51.54
VOLUME
5.63M
TURNOVER
--
52 WEEK HIGH
59.97
52 WEEK LOW
23.62
MARKET CAP
32.29B
P/E (TTM)
44.07
1D
5D
1M
3M
1Y
5Y
1D
Genmab Reports Share Sales by Two Board Members
TipRanks · 13h ago
Genmab Files Articles of Association Dated November 10
TipRanks · 17h ago
Genmab Discloses Executive Bradley Bailey’s Sale of 1,071 Shares
TipRanks · 17h ago
Genmab Reports November 10 Executive Share Sales
TipRanks · 18h ago
Genmab Announces DKK 369.7 Million Share Capital Increase From Employee Warrants
TipRanks · 2d ago
Bicara Therapeutics price target lowered to $37 from $39 at BTIG
TipRanks · 2d ago
ValuEngine Weekly Market Commentary With Outlook For The Remainder Of 2026
Seeking Alpha · 3d ago
Weekly Report: what happened at GMAB last week (1102-1106)?
Weekly Report · 3d ago
More
About GMAB
Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer. The Company is the creator of the approved antibodies: DARZALEX (daratumumab) for the treatment of certain multiple myeloma indications, Kesimpta for the treatment of adults with relapsing forms of multiple sclerosis, TEPEZZA (teprotumumab) for the treatment of thyroid eye disease and FASPRO, for the treatment of adult patients with certain multiple myeloma indications. The first approved Genmab created therapy Arzerra, approved for the treatment of certain chronic lymphocytic leukemia indications, is available in Japan and is also available in other territories via compassionate use or oncology access programs. Genmab develops a broad clinical and pre-clinical product pipeline, and owns four antibody technologies, DuoBody bispecific platform, HexaBody platform, DuoHexaBody platform & HexElect platform.

Webull offers Genmab A/S - ADR stock information, including NASDAQ: GMAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GMAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GMAB stock methods without spending real money on the virtual paper trading platform.